Navigation Links
Genomma Lab Announces the Successful Launch of the Ma Evans Brand
Date:12/11/2008

MEXICO CITY, Dec. 11 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), a leading Mexican over-the-counter ("OTC") pharmaceuticals and personal care products company announced today the successful launch of the personal hair care product line Ma Evans. The product launch was realized through a mass media campaign under the brand name "Ma Evans Evolution". The Company has been successful in placing the product in the market through its distribution channels. In addition, the product has been well-received at the point of sale, and has surpassed initial sales objectives. The product launch contains five SKU's in the anti-hair loss shampoo, anti-hair loss treatment and hair gel categories.

The Ma Evans brand was acquired by Genomma Lab during the fourth quarter 2007 due to its high level of brand recognition in the shampoo and anti-hair loss treatment categories. With this launch, Genomma Lab reinforces its presence in the hair care category, in which it currently participates under the anti-dandruff shampoo brand Medicasp. The market size of the Mexican hair care category is approximately Ps. 15 billion pesos(1).

With this launch, Genomma Lab confirms its capacity to acquire, transform and re-launch brands focused on the target consumer's likes and preferences.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab performed its Initial Public Offering in June, 2008, through a combined offering (mainly primary) and is listed on the Mexican Stock Exchange under the ticker symbol "LAB" (Bloomberg: labb.mx).

    Web Site: www.genommalab.com

    (1) Source:  Nielsen (2007)

    Investor Relations Contact:
    Tel: +52 (55) 5081 0000 Ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3692
    E-mail: genomma@i-advize.com

'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genomma Lab Announces 2009 Earnings Guidance
2. Genomma Lab Internacional Acquires UNIGASTROZOL
3. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
4. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
5. iSirona Announces New President and Chief Sales Officer
6. Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation
7. WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
8. Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals
9. Markel Corporation Announces New DataBreach(SM) Privacy Liability Coverage
10. Allscripts Announces Expiration of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
11. Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Mateo, CA (PRWEB) , ... ... ... Society (RSS), a non-profit medical society dedicated to advancing the science and ... leveraging data from its RSSearch Patient Registry, a multi-institutional, observational registry established ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System industry, introduced ... Plus. These iSAFE products are the most affordable and most advanced medical alert systems ... direct GPS Location and two-way calling with the push of a button on a ...
(Date:3/28/2017)... ... ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy Mikovits; Dr. Jennifer ... speak to the press on behalf of over 200 doctors, scientists, and scientific organizations ... , WHERE: , Zenger Room, National Press Club, 529 14th Street NW, 13th ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Radiology Business Management ... begun to serve as its new executive director. Mr. Still was selected through a ... , “Bob, as he is known to our members, has been a part ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... physicians, Paul Yost, will begin serving as new board chair for Orange County ... Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, which ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Kingdom and  BOSTON , March 28, 2017 ... Linguamatics today announced a partnership with premium ... agreement allows pharmaceutical companies to extract key insights ... text mining technology. The Linguamatics ... the top 20 global pharmaceutical companies. The Linguamatics-Dow ...
(Date:3/28/2017)... Md. , March 28, 2017  CASI ... to innovative therapeutics addressing cancer and other unmet ... the American Association for Cancer Research annual meeting.  ... 3 is entitled "Evaluation of ENMD-2076 in ... and the second poster to be presented on ...
(Date:3/28/2017)... England , March 28, 2017 ... collaborative research with Cambridge ... Therapeutics Consortium   The Milner Therapeutics Institute today ... Consortium. Elysium Health has committed significant investment for collaborative projects ... the next four years. This is the first major research ...
Breaking Medicine Technology: